Talazoparib suppressed tumour growth of ARID1A-mutant cancers in a xenograft model by reducing expression levels of checkpoint kinase 1 and increasing levels of apoptosis marker caspase 3 [119]. The gene discussed is ARID1A; the disease is neoplasm.